Difference between revisions of "Carcinoma ex pleomorphic adenoma"

From Libre Pathology
Jump to navigation Jump to search
(+infobox)
(more)
Line 24: Line 24:
| Rads      =
| Rads      =
| Endoscopy  =
| Endoscopy  =
| Prognosis  =
| Prognosis  = typically poor
| Other      =
| Other      =
| ClinDDx    =
| ClinDDx    =
Line 40: Line 40:
Epidemiology:
Epidemiology:
*Rare.
*Rare.
*Usually a poor prognosis.<ref name=pmid21744105/>


==Gross==
==Gross==
Line 75: Line 76:
#Minimally invasive <=1.5 mm beyond the capsule.
#Minimally invasive <=1.5 mm beyond the capsule.
#Widely invasive >1.5 mm beyond the capsule.
#Widely invasive >1.5 mm beyond the capsule.
===Images===
*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311945/figure/Fig1/ Ca ex PA - showing ca and PA areas (nih.gov)].<ref name=pmid21744105/>
*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311945/figure/Fig2/ Ca ex PA - showing capsule invasion (nih.gov)].


==See also==
==See also==

Revision as of 17:21, 23 November 2013

Carcinoma ex pleomorphic adenoma
Diagnosis in short
LM DDx salivary duct carcinoma, mucoepidermoid carcinoma, adenoid cystic carcinoma, pleomorphic adenoma
Site salivary gland - usu. parotid gland

Signs usu. parotid mass, firm
Prevalence uncommon
Prognosis typically poor

Carcinoma ex pleomorphic adenoma, abbreviated ca ex PA, is a rare malignant salivary gland tumour that arise from a pleomorphic adenoma.

General

Definition:

Diagnosis (either 1 or 2):

  1. History of a pleomorphic adenoma at the same site.
  2. Features of a pleomorphic adenoma and a carcinoma.

Epidemiology:

  • Rare.
  • Usually a poor prognosis.[1]

Gross

  • Usually mass lesion - partoid gland.[1]

Microscopic

Features:

  • Cells with cytologic features of malignancy - key feature.
  • Architecture (any of the following):
    • Glands.
    • Nests.
    • Single cells (may be subtle).

Architectural patterns:

Note:

  • Often adenocarcinoma-like.
  • Myoepithelial cells may be clear cells.

DDx:

Subclassification

Extent of invasion:[2]

  1. Non-invasive AKA intracapsular AKA in situ.
  2. Minimally invasive <=1.5 mm beyond the capsule.
  3. Widely invasive >1.5 mm beyond the capsule.

Images

See also

References

  1. 1.0 1.1 1.2 1.3 Antony, J.; Gopalan, V.; Smith, RA.; Lam, AK. (Mar 2012). "Carcinoma ex pleomorphic adenoma: a comprehensive review of clinical, pathological and molecular data.". Head Neck Pathol 6 (1): 1-9. doi:10.1007/s12105-011-0281-z. PMID 21744105.
  2. URL: http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/MajorSalGlands_11protocol.pdf. Accessed on: 2 April 2012.